#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16068	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2498	794.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1936	1936	T	1045	T,G,C,A	1039,3,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16068	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2498	794.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1670	1670	C	1089	C	1089	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3853	897.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1816	1816	A	1173	A,G	910,263	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3853	897.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2450	2450	C	981	C,T	980,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3853	897.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2524	2524	A	916	A,C	915,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3853	897.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3076	3076	C	1032	C,T	1029,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27782	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3853	897.6	0	HET	.	.	.	T695C,G	.	695	695	T	1174	1174	T	1022	T,C,G	803,217,2	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2522	folP	855	855	100.0	folP.l15.c17.ctg.1	1866	168.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1216	1218	AGC	275;276;279	A;G;C	275;276;279	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3655	189.0	1	SNP	p	S91F	1	.	.	271	273	TTC	737	739	TTC	215;215;218	T,A;T,C;C	214,1;214,1;218	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3655	189.0	1	SNP	p	D95G	1	.	.	283	285	GGC	749	751	GGC	219;216;216	G,C;G,C;C	218,1;215,1;216	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5546	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3655	189.0	1	SNP	p	G95N	0	.	.	283	285	GGC	749	751	GGC	219;216;216	G,C;G,C;C	218,1;215,1;216	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2078	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1729	150.0	1	SNP	p	G45D	1	.	.	133	135	GAC	678	680	GAC	244;246;247	G;A;C,A	244;246;246,1	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1214	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1308	115.3	0	.	n	.	0	A197.	DEL	197	197	A	758	758	A	238	A	238	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	752	754	AAC	259;260;257	A,G,T;A,C;C,A	257,1,1;259,1;256,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1799	1801	GCA	232;233;236	G;C;A,C	232;233;235,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	1	SNP	p	S87R	0	.	.	259	261	AGT	755	757	AGT	258;260;262	A,C;G,T;T,A	257,1;259,1;261,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	1	SNP	p	S87I	0	.	.	259	261	AGT	755	757	AGT	258;260;262	A,C;G,T;T,A	257,1;259,1;261,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	1	SNP	p	S87W	0	.	.	259	261	AGT	755	757	AGT	258;260;262	A,C;G,T;T,A	257,1;259,1;261,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3329	194.4	1	SNP	p	S88P	0	.	.	262	264	TCC	758	760	TCC	261;260;259	T,G;C,A;C,T	260,1;259,1;257,2	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4904	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3119	196.0	0	.	p	.	0	V89A	NONSYN	265	267	GTC	800	802	GCC	221;220;221	G;C;C	221;220;221	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4904	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3119	196.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1763	1765	GGC	277;276;273	G,A,T;G;C	275,1,1;276;273	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1457	1459	GCA	275;275;273	G,A;C;A	274,1;275;273	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1460	1462	ATC	270;269;268	A;T,A;C,A,T	270;268,1;266,1,1	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1472	1474	GTG	255;265;267	G,T;T,G;G	254,1;264,1;267	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1472	1474	GTG	255;265;267	G,T;T,G;G	254,1;264,1;267	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1976	1978	ACC	259;261;257	A;C;C	259;261;257	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2030	2032	GCG	239;237;238	G;C,G;G	239;236,1;238	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2030	2032	GCG	239;237;238	G;C,G;G	239;236,1;238	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2153	2155	GGC	242;244;246	G;G;C	242;244;246	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2162	2164	GGC	252;253;253	G;G;C	252;253;253	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2909	190.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2180	2182	CCG	249;249;247	C,G,T;CG,C;G,C,A	245,3,1;239,1;245,1,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6370	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3595	221.3	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1767	1769	ACG	273;274;275	A;C,T,A;G,T	273;272,1,1;273,2	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6370	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3595	221.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1905	1907	CTG	258;257;255	C,G;T;G	257,1;257;255	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2634	porA	1146	1146	99.74	porA.l6.c4.ctg.1	2139	153.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	525	527	GGC	179;181;182	G,T;G,T;C	178,1;180,1;182	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2634	porA	1146	1146	99.74	porA.l6.c4.ctg.1	2139	153.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	707	707	C	208	C	208	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	62.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	37;40;42	T;T;A	37;40;42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	62.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	77;77;77	C;A;T	77;77;77	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	62.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	77;77;77	A;G;T	77;77;77	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	62.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	77;77;77	T;A;C,A	77;77;76,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	T26A	NONSYN	76	78	ACC	405	407	GCC	279;278;277	G,A;C;C,A	277,2;278;276,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	441	443	GAA	267;267;268	G;A;A	267;267;268	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	K41D	NONSYN	121	123	AAA	450	452	GAC	267;269;273	G,A;A;C,A	266,1;269;272,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	729	731	GAT	276;278;277	G;A;T	276;278;277	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	852	854	TCA	277;280;279	T,C;C;A	276,1;280;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	A218I	NONSYN	652	654	GCC	981	983	ATC	282;284;282	A;T;C,A	282;284;281,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	F222L	NONSYN	664	666	TTT	993	995	CTT	286;286;285	C;T;T	286;286;285	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	G255_T256insR	INS	763	763	G	1092	1092	G	268	G	267	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	N260S	NONSYN	778	780	AAT	1110	1112	AGT	263;264;262	A;G;T	262;263;261	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	0	.	p	.	0	D333E	NONSYN	997	999	GAC	1329	1331	GAA	312;314;313	G;A;A	312;314;313	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	1	SNP	p	G120K	1	.	.	358	360	AAG	687	689	AAG	285;283;278	A,C;A;G,T	284,1;283;277,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	1	SNP	p	D121N	0	.	.	361	363	GAC	690	692	GAC	279;280;282	G,T,A;A;C,A	277,1,1;280;281,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3216	porB1b	1047	1047	98.29	porB1b.l15.c30.ctg.1	1528	255.0	1	SNP	p	A121D	1	.	.	361	363	GAC	690	692	GAC	279;280;282	G,T,A;A;C,A	277,1,1;280;281,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10852	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5217	259.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2210	2212	AAT	292;295;292	A;A;T,A	292;295;291,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1546	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1470	131.4	1	SNP	p	V57M	1	.	.	169	171	ATG	727	729	ATG	257;251;250	A;T;G,T	257;251;249,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
